"The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the marketing of selexipag (Uptravi, Actelion Registration Ltd) for the treatment of adults with pulmonary arterial hypertension (PAH)./"...
Advise patients receiving INSPRA:
- Not to use potassium supplements or salt substitutes containing potassium without consulting the prescribing physician [see WARNINGS AND PRECAUTIONS].
- To call their physician if they experience dizziness, diarrhea, vomiting, rapid or irregular heartbeat, lower extremity edema, or difficulty breathing [see WARNINGS AND PRECAUTIONS].
Last reviewed on RxList: 5/16/2016
This monograph has been modified to include the generic and brand name in many instances.
Additional Inspra Information
Inspra - User Reviews
Inspra User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get tips on handling your hypertension.